| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/PR060010K |
| P698 | PubMed publication ID | 16823970 |
| P2093 | author name string | Kit S Lam | |
| Carlito B Lebrilla | |||
| Hyun Joo An | |||
| Bensheng Li | |||
| Crystal Kirmiz | |||
| Gary S Leiserowitz | |||
| Katherine S Lancaster | |||
| Suzanne Miyamoto | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| biomarker | Q864574 | ||
| P304 | page(s) | 1626-1635 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer | |
| P478 | volume | 5 |
| Q33728755 | A Method for In-Depth Structural Annotation of Human Serum Glycans That Yields Biological Variations |
| Q33250468 | A serum glycomics approach to breast cancer biomarkers |
| Q34657423 | Advances in MALDI mass spectrometry in clinical diagnostic applications |
| Q33282042 | Alterations in the serum glycome due to metastatic prostate cancer |
| Q34593205 | Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. |
| Q35891802 | Analyzing a Mixture of Disaccharides by IMS-VUVPD-MS. |
| Q38097532 | Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma |
| Q37961971 | Application of nano-LC-based glycomics towards biomarker discovery |
| Q36860100 | Automated glycopeptide analysis--review of current state and future directions |
| Q39418711 | Automatic annotation and visualization tool for mass spectrometry-based glycomics |
| Q34574366 | Boronic acid-functionalized detonation nanodiamond for specific enrichment of glycopeptides in glycoproteome analysis |
| Q34404795 | CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations |
| Q37307199 | Cancer biomarkers: are we ready for the prime time? |
| Q47680478 | Capillary electrophoresis-mass spectrometry for direct structural identification of serum N-glycans |
| Q57697016 | Carbohydrate biomarkers for future disease detection and treatment |
| Q41863702 | Carbohydrate structural isomers analyzed by sequential mass spectrometry |
| Q37229796 | Chemical approaches to perturb, profile, and perceive glycans |
| Q36471241 | Chemoenzymatic method for glycomics: Isolation, identification, and quantitation |
| Q34022368 | Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. |
| Q58087849 | Clinical application of quantitative glycomics |
| Q34621113 | Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry |
| Q34975642 | Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis |
| Q35902976 | Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers |
| Q38778658 | DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins. |
| Q33689369 | Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity |
| Q36904030 | Defining putative glycan cancer biomarkers by MS. |
| Q35913954 | Delineating diseases by IMS-MS profiling of serum N-linked glycans |
| Q33392137 | Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data |
| Q33396321 | Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients |
| Q37084546 | Development of a robust and high throughput method for profiling N-linked glycans derived from plasma glycoproteins by NanoLC-FTICR mass spectrometry. |
| Q27026715 | Developments in the identification of glycan biomarkers for the detection of cancer |
| Q37154456 | Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system |
| Q51711833 | Disaccharide-driven transition of macroscopic properties: from molecular recognition to glycopeptide enrichment. |
| Q37402795 | Electron capture dissociation of divalent metal-adducted sulfated N-glycans released from bovine thyroid stimulating hormone. |
| Q35988424 | Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. |
| Q40228498 | Evolving '-omics' technologies in the drug development process. |
| Q92819463 | Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women |
| Q38773416 | Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery |
| Q37673558 | Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer |
| Q46188171 | Glycan Node Analysis: A Bottom-up Approach to Glycomics |
| Q41818458 | Glycan family analysis for deducing N-glycan topology from single MS. |
| Q38945184 | Glycans and glycoproteins as specific biomarkers for cancer |
| Q26782025 | Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review |
| Q33546544 | Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins |
| Q41866222 | Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker |
| Q81886862 | Glycomic profiling of invasive and non-invasive breast cancer cells |
| Q34601075 | Glycomic profiling of tissue sections by LC-MS |
| Q33291862 | Glycomics analysis of serum: a potential new biomarker for ovarian cancer? |
| Q37457130 | Glycomics and disease markers |
| Q41838773 | Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides. |
| Q46027049 | Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms. |
| Q39062915 | Hepatocellular carcinoma markers in the omics era: the glycomic analysis |
| Q33753523 | High-mannose glycans are elevated during breast cancer progression |
| Q93083938 | Highly Sensitive O-Glycan Profiling for Human Serum Proteins Reveals Gender-Dependent Changes in Colorectal Cancer Patients |
| Q35131557 | Highly efficient N-glycoproteomic sample preparation by combining C(18) and graphitized carbon adsorbents |
| Q33653461 | Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. |
| Q35262822 | Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery |
| Q34549268 | Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis |
| Q36904006 | Identifying cancer biomarkers by mass spectrometry-based glycomics |
| Q33404734 | Intact and top-down characterization of biomolecules and direct analysis using infrared matrix-assisted laser desorption electrospray ionization coupled to FT-ICR mass spectrometry |
| Q64910559 | Investigation of Sialylation Aberration in N-linked Glycopeptides By Lectin and Tandem Labeling (LTL) Quantitative Proteomics |
| Q33322900 | Investigations with O-linked protein glycosylations by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. |
| Q42132684 | Is high throughput glycomics possible? |
| Q42279918 | Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. |
| Q88095064 | Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses |
| Q33324569 | Mass spectrometric profiling of N-linked oligosaccharides and uncommon glycoform in mouse serum with head and neck tumor |
| Q35125544 | Mass spectrometric screening of ovarian cancer with serum glycans |
| Q33689810 | Methylamidation for Sialoglycomics by MALDI-MS: A Facile Derivatization Strategy for Both α2,3- and α2,6-Linked Sialic Acids |
| Q37099414 | Microchip electrophoresis of N-glycans on serpentine separation channels with asymmetrically tapered turns |
| Q50656806 | Microwave-assisted deglycosylation for rapid and sensitive analysis of N-glycans via glycosylamine derivatization. |
| Q36833668 | Multiplexed surrogate analysis of glycotransferase activity in whole biospecimens |
| Q35675417 | N-Glycan profiling of dried blood spots |
| Q36917567 | N-Glycan structure annotation of glycopeptides using a linearized glycan structure database (GlyDB) |
| Q34187614 | N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma. |
| Q47138416 | N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma |
| Q35874750 | N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. |
| Q37822160 | Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer |
| Q33760930 | O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma. |
| Q31139869 | On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve |
| Q35161829 | One-Year Plasma N-linked Glycome Intra-individual and Inter-individual Variability in the Chicken Model of Spontaneous Ovarian Adenocarcinoma |
| Q64972986 | Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine. |
| Q26823516 | Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop |
| Q37396485 | Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry |
| Q37055406 | Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS |
| Q34062987 | Protein biomarkers in cancer: natural glycoprotein microarray approaches |
| Q38500988 | Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays |
| Q35892699 | Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets |
| Q58687205 | Recent Advances in Electrochemical Glycobiosensing |
| Q48160092 | Recent Advances in the Mass Spectrometry Methods for Glycomics and Cancer. |
| Q33774597 | Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer |
| Q36582422 | Serum biomarkers identification by mass spectrometry in high-mortality tumors |
| Q35064779 | Serum glycan signatures of gastric cancer. |
| Q28079101 | Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers |
| Q45999306 | Serum glycosylation characterization of osteonecrosis of the femoral head by mass spectrometry. |
| Q28468580 | Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method |
| Q35217800 | Solid-phase methylamidation for sialoglycomics by MALDI-MS. |
| Q38604842 | Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry |
| Q45072735 | Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer. |
| Q35786742 | Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry |
| Q36098576 | Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis |
| Q46614544 | Structure elucidation of native N- and O-linked glycans by tandem mass spectrometry (tutorial). |
| Q30952867 | Taxonomic relationships of pollens from matrix-assisted laser desorption/ionization time-of-flight mass spectrometry data using multivariate statistics |
| Q37474863 | Technical advances in proteomics mass spectrometry: identification of post-translational modifications. |
| Q33447457 | The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome |
| Q33836040 | The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry |
| Q34383959 | The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. |
| Q35077893 | The immunomodulating roles of glycoproteins in epithelial ovarian cancer |
| Q47158443 | The proteins cleaved by endogenous tryptic proteases in normal EDTA plasma by C18 collection of peptides for liquid chromatography micro electrospray ionization and tandem mass spectrometry |
| Q80238171 | The sweet side of biomarker discovery |
| Q33400004 | Use of activated graphitized carbon chips for liquid chromatography/mass spectrometric and tandem mass spectrometric analysis of tryptic glycopeptides |
| Q38022218 | Using lectins to harvest the plasma/serum glycoproteome. |
Search more.